Jane Street’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-32,100
Closed -$2.97M 6228
2019
Q2
$2.97M Sell
32,100
-1,177,500
-97% -$112M 0.01% 1490
2019
Q1
$114M Buy
1,209,600
+867,400
+253% +$75.9M 0.19% 68
2018
Q4
$21.9M Buy
342,200
+263,600
+335% +$19.5M 0.05% 289
2018
Q3
$7.03M Sell
78,600
-121,600
-61% -$10.7M 0.01% 818
2018
Q2
$15.9M Sell
200,200
-68,100
-25% -$5.65M 0.04% 394
2018
Q1
$23.9M Buy
268,300
+213,500
+390% +$20.5M 0.06% 247
2017
Q4
$5.72M Sell
54,800
-60,000
-52% -$6.77M 0.02% 793
2017
Q3
$16.7M Sell
114,800
-8,900
-7% -$1.21M 0.05% 317
2017
Q2
$16.1M Buy
123,700
+17,800
+17% +$2.18M 0.06% 294
2017
Q1
$13.2M Buy
105,900
+58,900
+125% +$7.05M 0.06% 299
2016
Q4
$5.44M Sell
47,000
-78,300
-62% -$8.72M 0.02% 609
2016
Q3
$13.1M Sell
125,300
-11,300
-8% -$1.22M 0.06% 248
2016
Q2
$13.5M Buy
136,600
+82,200
+151% +$8.5M 0.07% 256
2016
Q1
$5.45M Buy
54,400
+33,200
+157% +$3.42M 0.03% 525
2015
Q4
$2.54M Sell
21,200
-31,000
-59% -$3.59M 0.02% 873
2015
Q3
$5.65M Buy
52,200
+33,400
+178% +$4.14M 0.04% 416
2015
Q2
$2.18M Sell
18,800
-36,200
-66% -$4.14M 0.01% 944
2015
Q1
$6.34M Buy
55,000
+52,800
+2,400% +$6.31M 0.05% 314
2014
Q4
$246K Buy
+2,200
New +$232K ﹤0.01% 2051

Other funds holding CELG

Jane Street's CELG Position: Q4 2019 in Review

Jane Street sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 36,809 shares — an estimated $3.66M sold.

Jane Street first reported a position in CELG in Q2 2013 and held it in 25 quarters. The position peaked at $63.8M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Jane Street reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Jane Street sold 36,809 Celgene Corp shares in Q4 2019, an estimated $3.66M.
  • Jane Street first reported a position in Celgene Corp in Q2 2013 and held it in 25 quarters.
  • Jane Street's Celgene Corp position peaked at $63.8M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Jane Street's 13F filing for Q4 2019, filed 14 Feb 2020.